Generate Biomedicines has filed for an IPO on the Nasdaq, seeking to raise upwards of $100 million for its AI-powered drug discovery operations. Incubated by Flagship Pioneering, Generate applies AI ...
Generate Biomedicines has completed its IPO, raising an impressive $400 million that makes it the largest listing for a biotech on the Nasdaq so far this year. Incubated by investment group Flagship ...
过去一两年，ChatGPT 等 AI 聊天工具凭借强大信息处理能力，成为工作中的 “万能顾问”，高效搞定写邮件、解疑问等需求。但面对业务执行场景，它们暴露短板：仅能提供方案，缺乏行动力、无法集成内部系统、难串联复杂流程，始终是 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果